Highlights Zomedica Corp.

Equities

ZOM

CA98980M1095

Market Closed - Nyse Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
0.1737 ^USD	-5.75%		+27.63%	-13.24%

05-15	Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform	CI
05-09	Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform	05-15	CI
Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M	05-09	MT
Zomedica Corp. Provides Revenue Guidance for Full Year 2024	05-09	CI
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Zomedica Seeks Acquisitions	04-01	CI
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	04-01	MT
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	04-01	CI
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	03-14	CI
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024	01-17	CI
Zomedica Corp. Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease	12-18	CI
Zomedica Announces Presentation of Clinical Data in Support of New Indications for Pulsevet Shock Wave Therapy	12-06	CI
Earnings Flash (ZOM) ZOMEDICA Posts Q3 Revenue $6.3M	11-13	MT
Zomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Zomedica Corp. acquired Qorvo Biotechnologies, LLC from Qorvo US, Inc. for $11.3 million.	04/10/23	CI
Zomedica Corp. Launches its Newest Assay - Endogenous ACTH	14/09/23	CI
Zomedica Pharmaceuticals Issued Warning From NYSE American For Failing to Meet Listing Requirement	13/09/23	MT
Zomedica Completes Acquisition of Structured Monitoring Products	05/09/23	MT
Earnings Flash (ZOM) ZOMEDICA Posts Q2 Revenue $6M	10/08/23	MT
Zomedica Seeks M&A Opportunities	10/08/23	CI
Zomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zomedica Corp.

Equities

ZOM

CA98980M1095

Highlights

Filters